These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27424166)

  • 21. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
    Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
    J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.
    Rash CJ; Stitzer M; Weinstock J
    J Subst Abuse Treat; 2017 Jan; 72():10-18. PubMed ID: 27746057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The construct and predictive validity of different approaches to combining urine and self-reported drug use measures among older adolescents after substance abuse treatment.
    Lennox R; Dennis ML; Ives M; White MK
    Am J Addict; 2006; 15 Suppl 1():92-101. PubMed ID: 17182424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
    Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
    Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study.
    Aharonovich E; Liu X; Samet S; Nunes E; Waxman R; Hasin D
    Am J Psychiatry; 2005 Aug; 162(8):1507-14. PubMed ID: 16055773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug use and validity of substance use self-reports in veterans seeking help for posttraumatic stress disorder.
    Calhoun PS; Sampson WS; Bosworth HB; Feldman ME; Kirby AC; Hertzberg MA; Wampler TP; Tate-Williams F; Moore SD; Beckham JC
    J Consult Clin Psychol; 2000 Oct; 68(5):923-7. PubMed ID: 11068979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency.
    Franz F; Angerer V; Jechle H; Pegoro M; Ertl H; Weinfurtner G; Janele D; Schlögl C; Friedl M; Gerl S; Mielke R; Zehnle R; Wagner M; Moosmann B; Auwärter V
    Clin Chem Lab Med; 2017 Aug; 55(9):1375-1384. PubMed ID: 28130957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine drug testing for social service agencies in Nova Scotia, Canada.
    Fraser AD
    J Forensic Sci; 1998 Jan; 43(1):194-6. PubMed ID: 9456542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contingency management interventions for HIV-related behaviors.
    Haug NA; Sorensen JL
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):154-9. PubMed ID: 17032574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contingency contracting with polydrug-abusing methadone patients.
    Magura S; Casriel C; Goldsmith DS; Strug DL; Lipton DS
    Addict Behav; 1988; 13(1):113-8. PubMed ID: 3284282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The behavioral profile of spice and synthetic cannabinoids in humans.
    Müller HH; Kornhuber J; Sperling W
    Brain Res Bull; 2016 Sep; 126(Pt 1):3-7. PubMed ID: 26548494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicology and management of novel psychoactive drugs.
    Kersten BP; McLaughlin ME
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do police arrestees substitute legal highs for other drugs?
    Wilkins C; Parker K; Prasad J; Jawalkar S
    Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of avoidance and inflexibility in characterizing response to contingency management for cocaine use disorders: A secondary profile analysis.
    Stotts AL; Vujanovic A; Heads A; Suchting R; Green CE; Schmitz JM
    Psychol Addict Behav; 2015 Jun; 29(2):408-13. PubMed ID: 25134057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.
    Zaitsu K; Nakayama H; Yamanaka M; Hisatsune K; Taki K; Asano T; Kamata T; Katagai M; Hayashi Y; Kusano M; Tsuchihashi H; Ishii A
    Int J Legal Med; 2015 Nov; 129(6):1233-45. PubMed ID: 26349566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the many faces of synthetic cannabinoid toxicities.
    Alipour A; Patel PB; Shabbir Z; Gabrielson S
    Ment Health Clin; 2019 Mar; 9(2):93-99. PubMed ID: 30842917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.